Recevez plus de réponses des employeurs
Envoyez un CV adapté au poste en quelques minutes.
KU Leuven invites applications for a PhD fellowship within SPACE-MEL, a MSCA Doctoral Network advancing spatial single-cell omics for precision medicine. You will develop workflows to generate spatial transcriptome, protein and epigenome readouts, combining DBiT-seq and COMET technologies in collaboration with AtlasXomics and Intelligent Biodata.
The project includes 3–4 month secondments in the United States and Spain, with training in spatial epigenomic assays and data integration.
The PhD fellow will be based at KU Leuven under the supervision of Prof. Thierry Voet. Prof. Voet leads the KU Leuven Institute for Single Cell Omics, and his team develops wet-lab and computational methods for single-cell and spatial multi-omics, applying them to human development, ageing and disease. The institute brings together researchers from over 70 groups across KU Leuven, University Hospitals Leuven and VIB, providing a strong interdisciplinary environment for hands‑on training in advanced single-cell and spatial technologies.
Co‑supervisors of this doctorate will be Dr. Jon Pey, Intelligent Biodata, Spain (Academia); Dr. Jennifer Garbarino, AtlasXomics Inc., United States (Industry).
Your PhD will be performed in context of SPACE-MEL, which is an EU‑funded MSCA Doctoral Network advancing the next generation of spatial single‑cell omics technologies for precision medicine. Bringing together leading European universities, technology providers, clinical partners and innovative companies, the programme will address key experimental and computational challenges currently limiting the clinical translation of spatial biology.
In this doctorate you will develop a workflow to generate spatial transcriptome, protein and epigenome readouts from the same tissue section. The project will combine single-cell and spatial multi-omics with DBiT‑seq‑based spatial omics sequencing technology and COMET‑based spatial proteomics. This project is carried out in strong collaboration with academia/industry partners with visits to their laboratories expected: During a first secondment at AtlasXomics (3 months, United States; co‑supervisor Dr. Jennifer Garbarino), the candidate will receive training in spatial epigenomic assay development and DBiT‑seq‑based workflow optimisation. The resulting workflow will be applied to melanoma samples to characterise tumour and immune cell organisation across multiple molecular layers. During a secondment at Intelligent Biodata (4 months, Spain; co‑supervisor Dr. Jon Pey), the candidate will analyse the generated spatial multi‑omics data using advanced computational and AI‑supported integration approaches. Expected outcomes include optimised AXO DBiT‑seq/COMET workflows and high‑resolution spatial multi‑omics maps of melanoma heterogeneity.
One PhD position is available. The project has a duration of 36‑months.
The doctoral candidate (DC) will receive a 36‑month scholarship to cover her/his living costs. The gross amount of the doctoral scholarship is based on a living allowance that is dependent on a country correction coefficient which takes into account the cost of living in the country of the recruiting institution. For Belgium, the gross amount of the doctoral scholarship (tax‑free) will be approximately €3.120,64 per month if the DC is single with no dependent family members. It will be higher if the DC has a registered partner without income and/or dependent child(ren); it will be lower if the DC has a registered partner with income.
The cost of all training activities, including all expenses related to travel and accommodation to attend annual meetings and other network organised events will be paid by the network through the Horizon Europe MSCA‑DN grant. DCs will have access to a dedicated workspace and to research facilities. Bench/consumables costs to execute the research project will be covered by the institutions.
For more information contact Prof. dr. Thierry Voet, mail: thierry.voet@kuleuven.be.
Applications must be submitted by before August 31st at 17:00 Central European time.
KU Leuven strives for an inclusive, respectful and socially safe environment. We embrace diversity among individuals and groups as an asset. Open dialogue and differences in perspective are essential for an ambitious research and educational environment. In our commitment to equal opportunity, we recognize the consequences of historical inequalities. We do not accept any form of discrimination based on, but not limited to, gender identity and expression, sexual orientation, age, ethnic or national background, skin colour, religious and philosophical diversity, neurodivergence, employment disability, health, or socioeconomic status. For questions about accessibility or support offered, we are happy to assist you at this email address.